Approach to Cardiovascular Autonomic Dysfunction in Patients with Synucleinopathies
Authors:
- 7 August 2025
- journal article
- review article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (12) , 2092-2105
Abstract
Background: Autonomic dysfunction is a common feature of synucleinopathies such as Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and pure autonomic failure (PAF). Orthostatic hypotension (OH) and supine hypertension (SH) are hallmark manifestations of cardiovascular autonomic dysfunction that are increasingly recognized as contributors to long‐term adverse clinical outcomes such as accelerated cognitive decline, motor symptom exacerbation, and end‐organ damage. Several atypical presentations of OH, including coat‐hanger pain, cognitive fluctuation, postural instability, fatigue, exertional dyspnea, and falls, commonly overlap with motor and non‐motor features of synucleinopathies. This clinical overlap highlights the need for heightened awareness of the diverse and often subtle manifestations of OH in affected individuals. Although the general management of OH has been addressed in prior literature, a dedicated framework tailored to the pathophysiological and clinical nuances specific to synucleinopathies remains lacking. SH, despite its high prevalence and significant prognostic implications, has received minimal attention in existing reviews and is often overlooked in clinical practice. Objective: Given the growing recognition of cardiovascular autonomic dysfunction as a potentially modifiable contributor to disease progression and patient quality of life, a focused updated review is warranted to inform clinical decision‐making and guide future research in this evolving area. Results: This narrative review comprehensively discusses the approach to OH and SH in the context of synucleinopathies. Conclusions: The key topics addressed are the pathophysiology of OH and SH in synucleinopathies, diagnostic criteria and types of OH, diagnostic criteria of SH, and management strategies (non‐pharmacological, pharmacological, and novel/experimental).Keywords
This publication has 119 references indexed in Scilit:
- Supine Blood Pressure and Risk of Cardiovascular Disease and MortalityJAMA Cardiology, 2025
- Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathiesAnnals of Clinical and Translational Neurology, 2020
- Rivastigmine in Parkinson's Disease Dementia with Orthostatic HypotensionAnnals of Neurology, 2020
- Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotensionAnnals of Clinical and Translational Neurology, 2019
- Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathiesAnnals of Neurology, 2018
- Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?Movement Disorders Clinical Practice, 2016
- Elastic Abdominal Binders Attenuate Orthostatic Hypotension in Parkinson's DiseaseMovement Disorders Clinical Practice, 2015
- Pyridostigmine Treatment Trial in Neurogenic Orthostatic HypotensionArchives of Neurology, 2006
- Acute Orthostatic Hypotension When Starting Dopamine Agonists in Parkinson's DiseaseArchives of Neurology, 2000
- Efficacy of Midodrine vs Placebo in Neurogenic Orthostatic HypotensionJAMA, 1997